187 related articles for article (PubMed ID: 11716847)
21. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis.
Ajuebor MN; Singh A; Wallace JL
Am J Physiol Gastrointest Liver Physiol; 2000 Jul; 279(1):G238-44. PubMed ID: 10898767
[TBL] [Abstract][Full Text] [Related]
22. The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats.
Martín AR; Villegas I; La Casa C; Alarcón de la Lastra C
Eur J Pharmacol; 2003 Nov; 481(2-3):281-91. PubMed ID: 14642796
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.
Antonioli L; Fornai M; Colucci R; Ghisu N; Da Settimo F; Natale G; Kastsiuchenka O; Duranti E; Virdis A; Vassalle C; La Motta C; Mugnaini L; Breschi MC; Blandizzi C; Del Taca M
J Pharmacol Exp Ther; 2007 Aug; 322(2):435-42. PubMed ID: 17488880
[TBL] [Abstract][Full Text] [Related]
24. 5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration.
Cuzzocrea S; Rossi A; Mazzon E; Di Paola R; Genovese T; Muià C; Caputi AP; Sautebin L
Lab Invest; 2005 Jun; 85(6):808-22. PubMed ID: 15821759
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
[TBL] [Abstract][Full Text] [Related]
26. Preventive effects of guanosine on intestinal inflammation in 2, 4-dinitrobenzene sulfonic acid (DNBS)-induced colitis in rats.
Zizzo MG; Caldara G; Bellanca A; Nuzzo D; Di Carlo M; Serio R
Inflammopharmacology; 2019 Apr; 27(2):349-359. PubMed ID: 29907915
[TBL] [Abstract][Full Text] [Related]
27. Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats.
Okayama M; Hayashi S; Aoi Y; Nishio H; Kato S; Takeuchi K
Dig Dis Sci; 2007 Sep; 52(9):2095-103. PubMed ID: 17429720
[TBL] [Abstract][Full Text] [Related]
28. Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis.
Pallio G; Bitto A; Pizzino G; Galfo F; Irrera N; Minutoli L; Arcoraci V; Squadrito G; Macrì A; Squadrito F; Altavilla D
Eur J Pharmacol; 2016 Oct; 789():152-162. PubMed ID: 27450484
[TBL] [Abstract][Full Text] [Related]
29. The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats.
El-Medany A; Mahgoub A; Mustafa A; Arafa M; Morsi M
Eur J Pharmacol; 2005 Jan; 507(1-3):291-9. PubMed ID: 15659320
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic efficacy of osthole against dinitrobenzene sulphonic acid induced-colitis in rats.
Khairy H; Saleh H; Badr AM; Marie MS
Biomed Pharmacother; 2018 Apr; 100():42-51. PubMed ID: 29421581
[TBL] [Abstract][Full Text] [Related]
31. The Antioxidant and Anti-Inflammatory Properties of
Siracusa R; Fusco R; Peritore AF; Cordaro M; D'Amico R; Genovese T; Gugliandolo E; Crupi R; Smeriglio A; Mandalari G; Cuzzocrea S; Di Paola R; Impellizzeri D
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32245085
[TBL] [Abstract][Full Text] [Related]
32. Cyclo-oxygenase-2 inhibitors ameliorate the severity of experimental colitis in rats.
Karmeli F; Cohen P; Rachmilewitz D
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):223-31. PubMed ID: 10741939
[TBL] [Abstract][Full Text] [Related]
33. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
34. Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine.
Seguí J; Gironella M; Sans M; Granell S; Gil F; Gimeno M; Coronel P; Piqué JM; Panés J
J Leukoc Biol; 2004 Sep; 76(3):537-44. PubMed ID: 15197232
[TBL] [Abstract][Full Text] [Related]
35. Blockade of Poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis.
Zingarelli B; Szabó C; Salzman AL
Gastroenterology; 1999 Feb; 116(2):335-45. PubMed ID: 9922314
[TBL] [Abstract][Full Text] [Related]
36. Lack of beneficial effect of COX-2 inhibitors in an experimental model of colitis.
Lesch CA; Kraus ER; Sanchez B; Gilbertsen R; Guglietta A
Methods Find Exp Clin Pharmacol; 1999 Mar; 21(2):99-104. PubMed ID: 10327390
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis.
Zwolinska-Wcislo M; Brzozowski T; Ptak-Belowska A; Targosz A; Urbanczyk K; Kwiecien S; Sliwowski Z
World J Gastroenterol; 2011 Sep; 17(36):4076-89. PubMed ID: 22039321
[TBL] [Abstract][Full Text] [Related]
38. Colon-targeted celecoxib ameliorates TNBS-induced rat colitis: a potential pharmacologic mechanism and therapeutic advantages.
Lee Y; Kim W; Hong S; Park H; Yum S; Yoon JH; Jung Y
Eur J Pharmacol; 2014 Mar; 726():49-56. PubMed ID: 24462351
[TBL] [Abstract][Full Text] [Related]
39. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
40. PARP inhibition reduces acute colonic inflammation in rats.
Sánchez-Fidalgo S; Villegas I; Martín A; Sánchez-Hidalgo M; Alarcón de la Lastra C
Eur J Pharmacol; 2007 Jun; 563(1-3):216-23. PubMed ID: 17374531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
